Skip to content

Cytokinetics

US · CYTK #1564 by market cap Listed 1970
50.78 -0.68 -1.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $113
    Market Newswire · 2026/10/15
  • Rating change
    Wells Fargo Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $105
    Market Newswire · 2026/10/4
  • Rating change
    Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $110
    Market Newswire · 2026/8/27
  • A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $78 to $140
    Market Newswire · 2026/11/5
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/9/10
  • Rating change
    Morgan Stanley Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103
    Market Newswire · 2026/11/3
  • Rating change
    A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $85 to $140
    Market Newswire · 2026/9/1
  • Rating change
    RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
    Market Newswire · 2026/9/10
  • Rating change
    J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating
    Market Newswire · 2026/10/14
  • Rating change
    UBS Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $104
    Market Newswire · 2026/10/15
  • Rating change
    UBS Maintains Cytokinetics(CYTK.US) With Buy Rating, Cuts Target Price to $104
    Market Newswire · 2026/10/14
  • Rating change
    BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Maintains Target Price $85
    Market Newswire · 2026/8/31
  • Rating change
    BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Cuts Target Price to $81
    Market Newswire · 2026/10/19
  • Rating change
    RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $113
    Market Newswire · 2026/10/8
  • A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140
    Market Newswire · 2026/11/6
  • Rating change
    Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
    Market Newswire · 2026/10/5
  • Rating change
    Barclays Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $110
    Market Newswire · 2026/8/14
  • Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
    Market Newswire · 2026/11/6
  • H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $140
    Market Newswire · 2026/11/9
  • Citi Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $105
    Market Newswire · 2026/11/7
  • Rating change
    Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $112
    Market Newswire · 2026/9/2
  • Rating change
    Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $112
    Market Newswire · 2026/8/13
  • Rating change
    J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $103
    Market Newswire · 2026/8/13
  • Rating change
    A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $100 to $140
    Market Newswire · 2026/8/8
  • H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $140
    Market Newswire · 2026/10/20

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.

Cytokinetics discussion 0 comments

Add a comment